Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 1,483 | 2,467 | 433 | 1,026 | 82 |
| Gross Profit | 1,483 | 2,467 | 433 | 1,026 | 82 |
| Operating Expenses | 7,826 | 7,879 | 7,005 | 8,056 | 10,153 |
| Operating Income | -6,343 | -5,412 | -6,572 | -7,030 | -10,071 |
| Interest Expense | 570 | 579 | 549 | 493 | 637 |
| Other Income | 28,731 | -16,172 | 11,125 | -1,465 | 14,207 |
| Pre-tax Income | 21,818 | -22,163 | 4,004 | -8,988 | 3,499 |
| Net Income Continuous | 21,818 | -22,163 | 4,004 | -8,988 | 3,499 |
| Net Income | $21,818 | $-22,163 | $4,004 | $-8,988 | $3,499 |
| EPS Basic Total Ops | 1.86 | -1.80 | 0.30 | -0.80 | 0.26 |
| EPS Basic Continuous Ops | 1.82 | -1.84 | 0.34 | -0.76 | 0.27 |
| EPS Diluted Total Ops | 1.27 | -1.80 | -0.60 | -0.80 | 0.26 |
| EPS Diluted Continuous Ops | 1.88 | -1.84 | 0.31 | -0.76 | 0.27 |
| EBITDA(a) | $-6,343 | $-5,411 | $-6,575 | $-7,025 | $-10,039 |